Skip to main content
. 2023 Aug 18;15(8):2157. doi: 10.3390/pharmaceutics15082157

Figure 1.

Figure 1

Synthesis and characterization of DSPE-PEG2000-RGD. (A) Synthesis route of DSPE-PEG2000-RGD. (B) 1H NMR spectra of DSPE-PEG2000-MAL and DSPE-PEG2000-RGD. (C) MALDI-TOF-MS spectra of DSPE-PEG2000-MAL and DSPE-PEG2000-RGD. (D) FT-IR spectra of DSPE-PEG2000-MAL, RGD, and DSPE-PEG2000-RGD.

HHS Vulnerability Disclosure